
FDA Approves First COVID-19 Treatment for Young Children
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing …
FDA Approves First COVID-19 Treatment for Young Children Read More